Sientra officials celebrate being listed on the Nasdaq after an IPO in October 2014. For months, Goleta breast implant manufacturer Sientra has been dogged by allegations that implants made by its Brazilian manufacturer, Silimed, were contaminated with particles of silica and cotton. Now plastic surgeons are questioning why Sientra products are not being sold after…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
